Article Abstract

Neoadjuvant DCF vs. ACF for resectable oesophageal squamous cell carcinoma

Authors: Vasiliki Michalarea, Elizabeth C. Smyth

Abstract

Despite falling incidence rates, squamous cell carcinoma of the oesophagus (OSCC) remains a common cancer globally; in 2012 an estimated 398,000 OSCC diagnoses were made worldwide (1-3).